Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and warfarin after total replacement of large joints - Our experience;Komplikace a rizika profylaktické antikoagulační léčby prováděné kombinací nízkomolekulárního heparinu (LMWH) a Warfarinu po implantaci TEP velkých kloubů - Naše zkuš enosti

Acta Chirurgiae Orthopaedicae et Traumatologiae Cechoslovaca

Volumn 71, Issue 4, 2004, Pages 237-244

  Míka, Pavel ^a   Behounek J ^a   Skotak M ^a   Nevsimal L ^a  

^a Nemocnice Pelh imov   (Czech Republic)

Author keywords

Follow up; Low molecular weight heparin; Prevention; Thromboembolism; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; VINPOCETINE; WARFARIN;

ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIET THERAPY; DOSE RESPONSE; FOLLOW UP; GENERAL PRACTITIONER; HEMATOMA; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTERNATIONAL STANDARD UNIT; JOINT PROSTHESIS; LONG TERM CARE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT MONITORING; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PREOPERATIVE PERIOD; PRESCRIPTION; RISK ASSESSMENT; STATISTICAL ANALYSIS; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT FAILURE;

EID: 4644303985     PISSN: 00015415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BERGQVIST, D., BENONI, G., BJORGELL, O., FREDIN, H., HEDLUNDH, U., NICOLAS, S., NILSSON, P., NYLANDER, G.: Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis Against Venous Thromboembolism after Total Hip Replacement. N. Engl. J. Med., 335: 696-700, 1996.
2. COLWELL, C.W., COLLIS, D. K., PAULSON, R., McCUTCHEN, J. W, BIGLER, G. T., LUTZ, S., HARDWICK, M. E.: Comparison of Enoxaparin end Warfarin for the Prevention of Venous Thromboembolic Disease after Total Hip Arthroplasty. J. Bone Jt Surg., 81-A: 932-940, 1999.
3. ČEPELÁK, V.: Prevence a léčba ž ilní trombózy. Med. Rev., 5: 12-15, 1998.
4. DŽUPA, V., PAZDÍREK, P., DOUŠA, P.: První zkušenosti s využitím přístroje Artroflow. Acta Chir. orthop. Traum. čech., 63: 298-300, 1996.
5. FRANCIS, CH. W., PELLEGRINI, V. D., MARDER, V. J., TOTTERMAN, S., HARRIS, C. M., GABRIEL, K. R., AZODO, M. V., LEIBERT, K. M.: Comparison of Warfarin and External Pneumatic Compression in Prevention of Venous Thrombosis after Total Hip Replacement. JAMA, 267-21: 2911-2915, 1992.
6. FRANCIS, CH., PELLEGRINI, V., TOTTERMAN, S., BOYD, A., MARDER, V., LIEBERT, K., STULBERG, B., AYERS, D., ROSENBERG, A., KESSLER, C., JOHANSON, N.: Prevention of Deep-Vein Thrombosis after Total Hip Arthroplasty. Comparison of Warfarin end Dalteparin. J. Bone Jt Surg., 79-A: 1365-1372, 1997.
7. FRIEDMAN, R. J., DAVIDSON, B. L., HEIT, J., KESSLER, C., ELLIOTT, C. G.: RD Heparin Compared with Warfarin for Prevention of Venous Thromboembolic Disease Following Total Hip or Knee Arthroplasty. J. Bone Jt Surg., 76-A: 1174-1185, 1994.
8. HAMULYAK, K., LENSING, A. W., VAN DER MEER, J., SMID, W. M., VAN OOY, A., HOEK, J. A.: Subcutaneous Low-Molecular-Weight Heparin or Oral Anticoagulants for The Prevention of Deep Vein Thrombosis in Elective Hip and Knee Replacement? Thromb. Haemost., 74: 1428-1431, 1995.
9. HAWKINS, D. W., LANGLEY, P. C., KRUEGER, K. P.: A Pharmacoeconomic Assessment of Enoxaparin and Warfarin as Prophylaxis for Deep Vein Thrombosis in Patients Undergoing Knee Replacement Surgery. Clin. Ther., 20: 182-195, 1998.
10. HEIT, J., KESSLER, C., MAMMEN, E.: Efficacy and Safety of RD Heparin (a LMWH) Versus Warfarin for Prevention of Deep-Vein Thrombosis after Hip or Knee Replacement. Blood, 78 (Suppl): 187, 1991.
11. HULL, R. D., PINEO, G. F., FRANCIS, CH., BERGQVIST, D., FELLENIUS, C., SODERBERG, K., HOLMQVIST, A., MANT, M., DEAR, R., BAYLIS, B., MAH, A., BRANT, R.: Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty Patients. Original Investigation. Arch: Int. Med., 160: 2208-2215, 2000.
12. HULL, R. D., PINEO, G. F., FRANCIS, CH., BERGQVIST, D., FELLENIUS, C., SODERBERG, K., HOLMQVIST, A., MANT, M., DEAR, R., BAYLIS, B., MAH A., BRANT, R.: Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients. Arch. Int. Med., 160: 2199-2207, 2000.
13. HULL, R. D., PINEO, G. F., STEIN, P. D., MAH, A. F., MACISAAC, S. M., DAHL, O. E., GHALI, W. A., BUTCHER, M. S., BRANT, R. F., BERGQVIST, D., HAMULYÁK, K., FRANCIS, CH. W., MARDER, V. J., RASKOB, G. E.: Timing of Initial Administration of Low-Molecular-Weight Heparin Prophylaxis Against Deep Vein Thrombosis in Patients Following Elective Hip Arthroplasty. A Systematic Review. Arch. Int. Med., 161: 1952-1960, 2001.
14. HULL, R. D., RASKOB, G. E., PINEO, G. F., FELDSTEIN, W., ROSENBLOOM, D., GAFNI, A., GREEN, D., FEINGLASS, J., TROWBRIDGE, A. A., ELLIOTT, C. G., LERNER, R. G., BRANT, R.: Subcutaneous Low-Molecular-Weight Heparin vs Warfarin for Prophylaxis of Deep Vein Thrombosis after Hip or Knee Implantation. An Economic perspective. Arch. Int. Med., 157: 298-303, 1997.
15. HULL, R., RASKOB, G., PINEO, G., ROSENBLOOM, D., EVANS, W., MALLORY, T., ANQUIST, K., SMITH, F., HUGHES, G., GREN, D., ELLIOT, G., PANJU, A., BRANT, R.: A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis Against Deep-Vein Thrombosis After Hip or Knee Implantation. N Engl J Med., 329-19: 1370-1376, 1993.
16. HYLEK, E. M., HEIMAN, H.: Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation. JAMA, 279: 657-662, 1998.
17. JORGENSON, L. N., WILLE-JORGENSON, P., HAUCH, O.: Prophylaxis of Postoperative Thromboembolism with Low-Molecular-Weight Heparins. Brit. J. Surg., 80: 689-704, 1993.
18. KESSLER, P.: Léčba orálními antikoagulancii. Praha, Orion Pharma 2000.
19. LENSING, A. W., PRINS, M. H., DAVIDSON, B. L.: Treatment of Deep Venous Thrombosis with Low-Molecular-Weight Heparins: a Meta-Analysis. Arch. Int. Med., 155(6): 601-607, 1995.
20. MATZSCH, T., BERGQVIST, D., FREDIN, H., HEDNER, U.: Low-Molecular-Weight Heparin Compared with Dextran as Prophylaxis Against Thrombosis After Total Hip Replacement. Acta chir. scand., 156: 445-450, 1990.
21. MURRAY, D. W., BRITTON, A. R., BULSTRODE, C. J. K.: Thromboprophylaxis and Death after Total Hip Replacement. J. Bone Jt Surg., 78-B: 863-870, 1996.
22. O'BRIEN, B. J., ANDERSON, D. R., GOEREE, R.: Cost-Effectiveness of Anoxaparin Versus Warfarin Prophylaxis Against Deep-Vein Thrombosis after Total Hip Replacement. Canad. med. Ass. J., 150: 1083-1090, 1994.
23. PAIMENT, G. D., WESSINGER, S. J., HUGHES, R., HARRIS, W. H.: Routine Use of Adjusted Low-Dose Warfarin to Prevent Venous Thromboembolism after Total Hip Replacement. J. Bone Jt Surg., 75-A: 893-898, 1993.
24. PLANES, A., VOCHELLE, N., DARMON, J. Y., FAGOLA, M., BELLAUD, M., HUET, Y.: Risk of Deep-Venous Thrombosis after Hospital Discharge in Patients Having Undergone Total Hip Replacement: Double-Blind Randomised Comparison of Enoxaparin Versus Placebo. Lancet, 348: 224-228, 1996.
25. PRANDONI, P., BRUCHI, O., SABBION, P., TANDUO, C., SCUDELLER, A., SARDELLA, C., ERRIGO, G., PIETROBELLI, F., MASO, G., GIROLAMI, A.: Prolonged Thromboprophylaxis with Oral Anticoagulants after Hip Arthroplasty. Arch. Int. Med., 162: 1966-1971, 2002.
26. SIRAGUSA, S., COSMI, B., PIOVELLA, F.: Low-Molecular-Weight Heparins and Unfractionated Heparin in the Treatment of Patients with Acute Venous Thromboembolism: Results of a Meta-Analysis. Amer. J. Med., 100(3): 269-277, 1996.
27. STEHLÍK, J., KARPAŠ, K., URBAN, K.: Srovnání tromboembolické profylaxe Heparinem a Fraxiparinem po TEP kyčelního kloubu. Acta Chir. orthop. Traum. čech., 62: 36-39, 1995.
28. TURPIE, A., GALLUS, A., HOEK, J.: A Synthetic Pentasaccharide for the Prevention od Deep-Vein Thrombosis after Total Hip Replacement. N. Engl. J. Med., 344: 619-625, 2001.
29. VALENTA, J., ŠIMÁK, J.: Prevence žilní tromboembolické nemoci. Rozhl. Chir., 79: 3-8, 2000.
30. WHITE, R. H., McKITTRICK, T., TAKAKUWA, J., CALLAHAN, C., McDONELL, M., FIHN, S.: Management and Prognosis of Life-threatening Bleeding during Warfarin Therapy. Arch. Int. Med., 6-10: 1197-1201, 1996.
31. WOOLSON, S. T., WATT, J. M.: Intermittent Pneumatic Compression to Prevent Proximal Deep Venous Thrombosis During and after Total Hip Replacement. A Prospective, Randomized Study od Compression Alone, Compression and Aspirin, and Compression and Low-Dose Warfarin. J. Bone Jt Surg., 73-A: 507-512, 1991.
32. YACOVELLA,T., ALTER,M., ČEPELÁK, V.: Antikoagulační léčba žilní trombembolické nemoci. Jaké jsou současné možnosti? Medicína po promoci, 2: 47-55, 2001.
33. ZEMAN, J., DUNGL, P., FAJTOVÁ, A., ŠTĚDRÝ, V., JERIEOVÁ, G.: Zjištování rizika trombózy dolních končetin po implantaci endoprotézy kyčelního kloubu ve fázi rehabilitace po propuštění z nemocnice. Praktická flebologie, 1: 20-26, 1999.